Real-World Evidence (RWE): How to Use It Right for FDA and EU MDR Compliance

Real-World Evidence (RWE) is transforming how regulators evaluate medical devices — but many manufacturers still struggle to use it correctly.

In this episode, we break down what RWE really means, how it differs between the FDA and the EU MDR, and how you can design a compliant, global strategy that turns data into regulatory strength.

You’ll learn:

What qualifies as Real-World Data (RWD) and Real-World Evidence (RWE)

How the FDA integrates RWE into premarket submissions (510(k), De Novo, PMA)

How EU MDR uses RWE through PMCF and PMS

The key differences in approach between the two regions

A practical 5-step roadmap to build a compliant RWE strategy

Common pitfalls (bias, poor traceability, privacy issues) — and how to avoid them

💡 Whether you’re in Regulatory Affairs, Clinical Affairs, or Quality Assurance, this episode gives you a clear framework to make Real-World Evidence a competitive advantage, not a compliance headache.

Who is Monir El Azzouzi?

Monir El Azzouzi is a Medical Device Expert specializing in Quality and Regulatory Affairs. After working for many years with big Healthcare companies, particularly Johnson and Johnson, he decided to create EasyMedicalDevice.com to help people better understand Medical Device Regulations worldwide. He has now created the consulting firm Easy Medical Device GmbH and developed many ways to deliver knowledge through videos, podcasts, online courses… His company also acts as Authorized Representative for the EU, UK, and Switzerland. Easy Medical Device becomes a one-stop shop for medical device manufacturers that need support on Quality and Regulatory Affairs.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is powered by Podcastics, the easiest platform to create and publish your podcast.